Загрузка...
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
Denosumab is a potent antiresorptive agent that substantially increases bone mineral density and reduces fracture rates at all skeletal sites for as long as it is administered. However, its favorable skeletal effects reverse quickly upon its discontinuation, because of a vast increase of osteoclast...
Сохранить в:
| Опубликовано в: : | J Clin Med |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7796169/ https://ncbi.nlm.nih.gov/pubmed/33406802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10010152 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|